Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Status:
Unknown status
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if and how often an unexpected fast increase of
disease and complaints shows after stopping the anti-angiogenetic therapy